Covered recipient · General Payments record
ANNA SUPONYA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,373.15
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.25 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $107.75 | 4 |
| Acerta Pharma LLC | $71.05 | 3 |
| ABBVIE INC. | $58.68 | 2 |
| INTRA-SANA LABORATORIES | $21.78 | 1 |
| Novo Nordisk AS | $17.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.98 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106184515 | CMS |
| ABBVIE INC. | $25.70 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106184517 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.34 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105311798 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.53 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104488968 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.18 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104223425 | CMS |
| Intra-Sana Laboratories | $21.78 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138620222 | CMS |
| Lilly USA, LLC | $24.11 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044854 | CMS |
| Lilly USA, LLC | $31.67 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136045947 | CMS |
| Lilly USA, LLC | $29.14 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044290 | CMS |
| Lilly USA, LLC | $22.83 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136056200 | CMS |
| Novo Nordisk Inc | $17.99 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096586685 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.